The Asia Pacific Transdermal Drug Delivery Systems Market would witness market growth of 5.4% CAGR during the forecast period (2022-2028).
Technological advancements such as the incorporation of mechanical arrays or microneedles in transdermal patches have provided further growth to the implementation of TDDS. The improvements include adjustments to transdermal patch designs, the addition of pressure-sensitive adhesives, and permeation enhancers, which have improved drug diffusion and boosted the reservoir's ability to hold more medication. Other improvements include reservoir-type transdermal patches and tiny, sophisticated transdermal patches that offer precise medicine doses.
In transdermal drug delivery systems more recently, microneedles have gained popularity, notably for the delivery of macromolecules or hydrophilic substances. The major skin barrier, the stratum corneum, can be crossed by microneedles, allowing access to the deeper layers of the epidermis. Skin permeability is greatly increased by this. Microneedles, in contrast to hypodermic injections, are minuscule enough to avoid coming into touch with the blood vessels and nerves in the dermis.
For a range of medication delivery applications, various kinds of microneedles with special qualities have been created. Solid microneedles can be utilized to improve permeability prior to drug application and are ideally suited for penetration. Hollow microneedles are utilized to make skin infusion routes for drugs. The medication coating on the surface of coated microneedles dissolves once they are inserted into the skin. In order to contain medications that completely dissolve in the skin and release their contained reagents, biodegradable and biocompatible polymer microneedles have also been developed.
In the Asia Pacific region, Japan turned out to be the country promoting transdermal drug delivery systems the most. This can be attributed to ongoing technological advancements, growing industry collaboration, and the expansion of market players' distribution networks. The older population of Japan has been on the rise for several years and has attracted the government's concern. A significant amount of healthcare, especially for the elderly is spent in the country.
The China market dominated the Asia Pacific Transdermal Drug Delivery Systems Market by Country in 2021; thereby, achieving a market value of $5,327.2 million by 2028. The Japan market is poised to grow at a CAGR of 4.8% during (2022 - 2028). Additionally, The India market would showcase a CAGR of 6.1% during (2022 - 2028).
Based on Application, the market is segmented into Analgesics, Hormone Replacement Therapies, Hypertension, Motion Sickness, Smoking Cessation and Others. Based on Type of Delivery System, the market is segmented into Passive and Active. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
Free Valuable Insights: The Worldwide Transdermal Drug Delivery Systems Market is Projected to reach USD 72.4 Billion by 2028, at a CAGR of 4.6%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Viatris Inc., Bayer AG, Boehringer Ingelheim GmbH, Endo International plc, GlaxoSmithKline plc, Johnson & Johnson, Novartis AG, Purdue Pharma L.P., Altaris and Hisamitsu Pharmaceutical Co. Inc.
Scope of the Study
Market Segments Covered in the Report:
By Application
- Analgesics
- Hormone Replacement Therapies
- Hypertension
- Motion Sickness
- Smoking Cessation
- Others
By Type of Delivery System
By Country
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
Key Market Players
List of Companies Profiled in the Report:
- Viatris Inc.
- Bayer AG
- Boehringer Ingelheim GmbH
- Endo International plc
- GlaxoSmithKline plc
- Johnson & Johnson
- Novartis AG
- Purdue Pharma L.P.
- Altaris
- Hisamitsu Pharmaceutical Co. Inc.
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Transdermal Drug Delivery Systems Market, by Application
1.4.2 Asia Pacific Transdermal Drug Delivery Systems Market, by Type of Delivery System
1.4.3 Asia Pacific Transdermal Drug Delivery Systems Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Asia Pacific Transdermal Drug Delivery Systems Market by Application
3.1 Asia Pacific Analgesics Market by Country
3.2 Asia Pacific Hormone Replacement Therapies Market by Country
3.3 Asia Pacific Hypertension Market by Country
3.4 Asia Pacific Motion Sickness Market by Country
3.5 Asia Pacific Smoking Cessation Market by Country
3.6 Asia Pacific Others Market by Country
Chapter 4. Asia Pacific Transdermal Drug Delivery Systems Market by Type of Delivery System
4.1 Asia Pacific Passive Market by Country
4.2 Asia Pacific Active Market by Country
Chapter 5. Asia Pacific Transdermal Drug Delivery Systems Market by Country
5.1 China Transdermal Drug Delivery Systems Market
5.1.1 China Transdermal Drug Delivery Systems Market by Application
5.1.2 China Transdermal Drug Delivery Systems Market by Type of Delivery System
5.2 Japan Transdermal Drug Delivery Systems Market
5.2.1 Japan Transdermal Drug Delivery Systems Market by Application
5.2.2 Japan Transdermal Drug Delivery Systems Market by Type of Delivery System
5.3 India Transdermal Drug Delivery Systems Market
5.3.1 India Transdermal Drug Delivery Systems Market by Application
5.3.2 India Transdermal Drug Delivery Systems Market by Type of Delivery System
5.4 South Korea Transdermal Drug Delivery Systems Market
5.4.1 South Korea Transdermal Drug Delivery Systems Market by Application
5.4.2 South Korea Transdermal Drug Delivery Systems Market by Type of Delivery System
5.5 Singapore Transdermal Drug Delivery Systems Market
5.5.1 Singapore Transdermal Drug Delivery Systems Market by Application
5.5.2 Singapore Transdermal Drug Delivery Systems Market by Type of Delivery System
5.6 Malaysia Transdermal Drug Delivery Systems Market
5.6.1 Malaysia Transdermal Drug Delivery Systems Market by Application
5.6.2 Malaysia Transdermal Drug Delivery Systems Market by Type of Delivery System
5.7 Rest of Asia Pacific Transdermal Drug Delivery Systems Market
5.7.1 Rest of Asia Pacific Transdermal Drug Delivery Systems Market by Application
5.7.2 Rest of Asia Pacific Transdermal Drug Delivery Systems Market by Type of Delivery System
Chapter 6. Company Profiles
6.1 Viatris, Inc.
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Segmental and Regional Analysis
6.1.4 Research & Development Expense
6.1.5 Recent strategies and developments:
6.1.5.1 Approval:
6.2 Purdue Pharma L.P.
6.2.1 Company Overview
6.3 Bayer AG
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Segmental and Regional Analysis
6.3.4 Research & Development Expense
6.4 Novartis AG
6.4.1 Company Overview
6.4.2 Financial Analysis
6.4.3 Segmental and Regional Analysis
6.4.4 Research & Development Expense
6.5 Boehringer Ingelheim International Gmbh
6.5.1 Company Overview
6.5.2 Financial Analysis
6.5.3 Regional & Segmental Analysis
6.5.4 Research & Development Expenses
6.6 GlaxoSmithKline PLC
6.6.1 Company Overview
6.6.2 Financial Analysis
6.6.3 Segmental and Regional Analysis
6.6.4 Research & Development Expense
6.7 Johnson & Johnson
6.7.1 Company Overview
6.7.2 Financial Analysis
6.7.3 Segmental &Regional Analysis
6.7.4 Research & Development Expenses
6.8 Endo International PLC
6.8.1 Company Overview
6.8.2 Financial Analysis
6.8.3 Segmental and Regional Analysis
6.8.4 Research & Development Expense
6.9 Altaris Capital Partners, LLC
6.9.1 Company Overview
6.9.2 Recent strategies and developments:
6.9.2.1 Acquisition and Mergers:
6.10. Hisamitsu Pharmaceutical Co. Inc.
6.10.1 Company Overview
6.10.2 Financial Analysis
6.10.3 Recent strategies and developments:
6.10.3.1 Approval:
TABLE 1 Asia Pacific Transdermal Drug Delivery Systems Market, 2018 - 2021, USD Million
TABLE 2 Asia Pacific Transdermal Drug Delivery Systems Market, 2022 - 2028, USD Million
TABLE 3 Asia Pacific Transdermal Drug Delivery Systems Market by Application, 2018 - 2021, USD Million
TABLE 4 Asia Pacific Transdermal Drug Delivery Systems Market by Application, 2022 - 2028, USD Million
TABLE 5 Asia Pacific Analgesics Market by Country, 2018 - 2021, USD Million
TABLE 6 Asia Pacific Analgesics Market by Country, 2022 - 2028, USD Million
TABLE 7 Asia Pacific Hormone Replacement Therapies Market by Country, 2018 - 2021, USD Million
TABLE 8 Asia Pacific Hormone Replacement Therapies Market by Country, 2022 - 2028, USD Million
TABLE 9 Asia Pacific Hypertension Market by Country, 2018 - 2021, USD Million
TABLE 10 Asia Pacific Hypertension Market by Country, 2022 - 2028, USD Million
TABLE 11 Asia Pacific Motion Sickness Market by Country, 2018 - 2021, USD Million
TABLE 12 Asia Pacific Motion Sickness Market by Country, 2022 - 2028, USD Million
TABLE 13 Asia Pacific Smoking Cessation Market by Country, 2018 - 2021, USD Million
TABLE 14 Asia Pacific Smoking Cessation Market by Country, 2022 - 2028, USD Million
TABLE 15 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
TABLE 16 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
TABLE 17 Asia Pacific Transdermal Drug Delivery Systems Market by Type of Delivery System, 2018 - 2021, USD Million
TABLE 18 Asia Pacific Transdermal Drug Delivery Systems Market by Type of Delivery System, 2022 - 2028, USD Million
TABLE 19 Asia Pacific Passive Market by Country, 2018 - 2021, USD Million
TABLE 20 Asia Pacific Passive Market by Country, 2022 - 2028, USD Million
TABLE 21 Asia Pacific Active Market by Country, 2018 - 2021, USD Million
TABLE 22 Asia Pacific Active Market by Country, 2022 - 2028, USD Million
TABLE 23 Asia Pacific Transdermal Drug Delivery Systems Market by Country, 2018 - 2021, USD Million
TABLE 24 Asia Pacific Transdermal Drug Delivery Systems Market by Country, 2022 - 2028, USD Million
TABLE 25 China Transdermal Drug Delivery Systems Market, 2018 - 2021, USD Million
TABLE 26 China Transdermal Drug Delivery Systems Market, 2022 - 2028, USD Million
TABLE 27 China Transdermal Drug Delivery Systems Market by Application, 2018 - 2021, USD Million
TABLE 28 China Transdermal Drug Delivery Systems Market by Application, 2022 - 2028, USD Million
TABLE 29 China Transdermal Drug Delivery Systems Market by Type of Delivery System, 2018 - 2021, USD Million
TABLE 30 China Transdermal Drug Delivery Systems Market by Type of Delivery System, 2022 - 2028, USD Million
TABLE 31 Japan Transdermal Drug Delivery Systems Market, 2018 - 2021, USD Million
TABLE 32 Japan Transdermal Drug Delivery Systems Market, 2022 - 2028, USD Million
TABLE 33 Japan Transdermal Drug Delivery Systems Market by Application, 2018 - 2021, USD Million
TABLE 34 Japan Transdermal Drug Delivery Systems Market by Application, 2022 - 2028, USD Million
TABLE 35 Japan Transdermal Drug Delivery Systems Market by Type of Delivery System, 2018 - 2021, USD Million
TABLE 36 Japan Transdermal Drug Delivery Systems Market by Type of Delivery System, 2022 - 2028, USD Million
TABLE 37 India Transdermal Drug Delivery Systems Market, 2018 - 2021, USD Million
TABLE 38 India Transdermal Drug Delivery Systems Market, 2022 - 2028, USD Million
TABLE 39 India Transdermal Drug Delivery Systems Market by Application, 2018 - 2021, USD Million
TABLE 40 India Transdermal Drug Delivery Systems Market by Application, 2022 - 2028, USD Million
TABLE 41 India Transdermal Drug Delivery Systems Market by Type of Delivery System, 2018 - 2021, USD Million
TABLE 42 India Transdermal Drug Delivery Systems Market by Type of Delivery System, 2022 - 2028, USD Million
TABLE 43 South Korea Transdermal Drug Delivery Systems Market, 2018 - 2021, USD Million
TABLE 44 South Korea Transdermal Drug Delivery Systems Market, 2022 - 2028, USD Million
TABLE 45 South Korea Transdermal Drug Delivery Systems Market by Application, 2018 - 2021, USD Million
TABLE 46 South Korea Transdermal Drug Delivery Systems Market by Application, 2022 - 2028, USD Million
TABLE 47 South Korea Transdermal Drug Delivery Systems Market by Type of Delivery System, 2018 - 2021, USD Million
TABLE 48 South Korea Transdermal Drug Delivery Systems Market by Type of Delivery System, 2022 - 2028, USD Million
TABLE 49 Singapore Transdermal Drug Delivery Systems Market, 2018 - 2021, USD Million
TABLE 50 Singapore Transdermal Drug Delivery Systems Market, 2022 - 2028, USD Million
TABLE 51 Singapore Transdermal Drug Delivery Systems Market by Application, 2018 - 2021, USD Million
TABLE 52 Singapore Transdermal Drug Delivery Systems Market by Application, 2022 - 2028, USD Million
TABLE 53 Singapore Transdermal Drug Delivery Systems Market by Type of Delivery System, 2018 - 2021, USD Million
TABLE 54 Singapore Transdermal Drug Delivery Systems Market by Type of Delivery System, 2022 - 2028, USD Million
TABLE 55 Malaysia Transdermal Drug Delivery Systems Market, 2018 - 2021, USD Million
TABLE 56 Malaysia Transdermal Drug Delivery Systems Market, 2022 - 2028, USD Million
TABLE 57 Malaysia Transdermal Drug Delivery Systems Market by Application, 2018 - 2021, USD Million
TABLE 58 Malaysia Transdermal Drug Delivery Systems Market by Application, 2022 - 2028, USD Million
TABLE 59 Malaysia Transdermal Drug Delivery Systems Market by Type of Delivery System, 2018 - 2021, USD Million
TABLE 60 Malaysia Transdermal Drug Delivery Systems Market by Type of Delivery System, 2022 - 2028, USD Million
TABLE 61 Rest of Asia Pacific Transdermal Drug Delivery Systems Market, 2018 - 2021, USD Million
TABLE 62 Rest of Asia Pacific Transdermal Drug Delivery Systems Market, 2022 - 2028, USD Million
TABLE 63 Rest of Asia Pacific Transdermal Drug Delivery Systems Market by Application, 2018 - 2021, USD Million
TABLE 64 Rest of Asia Pacific Transdermal Drug Delivery Systems Market by Application, 2022 - 2028, USD Million
TABLE 65 Rest of Asia Pacific Transdermal Drug Delivery Systems Market by Type of Delivery System, 2018 - 2021, USD Million
TABLE 66 Rest of Asia Pacific Transdermal Drug Delivery Systems Market by Type of Delivery System, 2022 - 2028, USD Million
TABLE 67 key information – Viatris, Inc.
TABLE 68 Key Information – Purdue Pharma L.P.
TABLE 69 Key Information – Bayer AG
TABLE 70 Key Information – Novartis AG
TABLE 71 Key Information – Boehringer Ingelheim International GmbH
TABLE 72 Key Information – GlaxoSmithKline PLC
TABLE 73 Key information – Johnson & Johnson
TABLE 74 Key Information – Endo International PLC
TABLE 75 Key Information – Altaris Capital Partners, LLC
TABLE 76 Key Information – Hisamitsu Pharmaceutical Co. Inc.
List of Figures
FIG 1 Methodology for the research